Literature DB >> 101457

Experimental production of respiratory tract disease in cebus monkeys after intratracheal or intranasal infection with influenza A/Victoria/3/75 or influenza A/New Jersey/76 virus.

M B Grizzard, W T London, D L Sly, B R Murphy, W D James, W P Parnell, R M Chanock.   

Abstract

A total of 28 cebus monkeys were inoculated intratracheally or intranasally with 10(6) 50% tissue culture infective doses of A/New Jersey/76 virus or 10(7) 50% tissue culture infective doses of A/Victoria/75 virus, and 8 additional monkeys received sterile allantoic fluid. Each of the animals became infected as evidenced by a serological response and/or shedding of the virus. Of the 10 animals inoculated intratracheally with A/Victoria/75 virus, 8 developed a systemic illness, and pulmonary infiltration was detected by X-ray in 7 of the 8. Administration of A/New Jersey/76 virus intratracheally to 10 monkeys produced a mild systemic illness in 2 animals and an upper respiratory tract illness in 6, but no illness developed in the remaining 2 monkeys; none of the animals developed X-ray evidence of lower respiratory tract disease. Intranasal administration of either virus failed to induce any illness or produced, at most, mild illness confined to the upper respiratory tract. These studies demonstrate that cebus monkeys are susceptible to respiratory tract infection with influenza A viruses and that the development of pulmonary disease is reflected in the appearance of easily recognizable radiological changes.

Entities:  

Mesh:

Year:  1978        PMID: 101457      PMCID: PMC421977          DOI: 10.1128/iai.21.1.201-205.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  12 in total

1.  AEROSOL EXPOSURE OF MONKEYS TO INFLUENZA VIRUS.

Authors:  S SASLAW; H N CARLISLE
Journal:  Proc Soc Exp Biol Med       Date:  1965-07

2.  Response of ferrets and monkeys to intranasal infection with human, equine and avian influenza viruses.

Authors:  P Marois; A Boudreault; E DiFranco; V Pavilanis
Journal:  Can J Comp Med       Date:  1971-01

3.  Antibodies to type A influenza viruses in sera from nonhuman primates.

Authors:  T C O'Brien; N M Tauraso
Journal:  Arch Gesamte Virusforsch       Date:  1973

4.  Use of subhuman primates in experimental infections.

Authors:  S Saslaw; H N Carlisle
Journal:  Ann N Y Acad Sci       Date:  1969-07-03       Impact factor: 5.691

5.  Persistence of Diplococcus pneumoniae after influenza virus infection in Macaca mulatta.

Authors:  R F Berendt; W E McDonough; J S Walker
Journal:  Infect Immun       Date:  1974-08       Impact factor: 3.441

6.  Serial transmission in rhesus monkeys of an agent related to hepatitis-associated antigen.

Authors:  W T London; H J Alter; J Lander; R H Purcell
Journal:  J Infect Dis       Date:  1972-04       Impact factor: 5.226

7.  Temperature-sensitive mutants of influenza virus. II. Attenuation of ts recombinants for man.

Authors:  B R Murphy; E G Chalhub; S R Nusinoff; R M Chanock
Journal:  J Infect Dis       Date:  1972-08       Impact factor: 5.226

8.  Influenza (A2-Hong Kong-68) in the baboon (Papio sp.).

Authors:  S S Kalter; R L Heberling; T E Vice; F S Lief; A R Rodriguez
Journal:  Proc Soc Exp Biol Med       Date:  1969-10

9.  Reaction of squirrel monkeys to intratracheal inoculation with influenza/A/New Jersey/76 (swine) virus.

Authors:  R F Berendt; W C Hall
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

10.  Simian model for the evaluation of immunity to influenza.

Authors:  R F Berendt
Journal:  Infect Immun       Date:  1974-01       Impact factor: 3.441

View more
  8 in total

Review 1.  The use of nonhuman primates in research on seasonal, pandemic and avian influenza, 1893-2014.

Authors:  A Sally Davis; Jeffery K Taubenberger; Mike Bray
Journal:  Antiviral Res       Date:  2015-03-05       Impact factor: 5.970

2.  Evaluation of replication, immunogenicity and protective efficacy of a live attenuated cold-adapted pandemic H1N1 influenza virus vaccine in non-human primates.

Authors:  Kobporn Boonnak; Myeisha Paskel; Yumiko Matsuoka; Leatrice Vogel; Kanta Subbarao
Journal:  Vaccine       Date:  2012-07-10       Impact factor: 3.641

3.  CD40-ligand in primate cardiac allograft and viral immunity.

Authors:  R N Pierson; J E Crowe; S Pfeiffer; J Atkinson; A Azimzadeh; G G Miller
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

4.  Plasmodium coatneyi in rhesus macaques replicates the multisystemic dysfunction of severe malaria in humans.

Authors:  Alberto Moreno; Monica Cabrera-Mora; Anapatricia Garcia; Jack Orkin; Elizabeth Strobert; John W Barnwell; Mary R Galinski
Journal:  Infect Immun       Date:  2013-03-18       Impact factor: 3.441

5.  Virulence of avian influenza A viruses for squirrel monkeys.

Authors:  B R Murphy; V S Hinshaw; D L Sly; W T London; N T Hosier; F T Wood; R G Webster; R M Chanock
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

6.  Evaluation of three strains of influenza A virus in humans and in owl, cebus, and squirrel monkeys.

Authors:  B R Murphy; D L Sly; N T Hosier; W T London; R M Chanock
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

Review 7.  Use of functional genomics to understand influenza-host interactions.

Authors:  Jamie L Fornek; Marcus J Korth; Michael G Katze
Journal:  Adv Virus Res       Date:  2007       Impact factor: 9.937

Review 8.  Animal models for the risk assessment of viral pandemic potential.

Authors:  Mee Sook Park; Jin Il Kim; Joon-Yong Bae; Man-Seong Park
Journal:  Lab Anim Res       Date:  2020-04-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.